NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
17.10
-0.67 (-3.77%)
At close: Aug 21, 2026, 4:00 PM EDT
17.55
+0.45 (2.63%)
After-hours: Aug 21, 2026, 7:30 PM EDT

NovoCure Revenue

NovoCure had revenue of $183.58M in the quarter ending June 30, 2026, with 15.60% growth. This brings the company's revenue in the last twelve months to $699.19M, up 10.95% year-over-year. In the year 2025, NovoCure had annual revenue of $655.35M with 8.28% growth.

Revenue (ttm)
$699.19M
Revenue Growth
+10.95%
P/S Ratio
2.85
Revenue / Employee
$435,634
Employees
1,605
Market Cap
1.99B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025655.35M50.13M8.28%
Dec 31, 2024605.22M95.88M18.82%
Dec 31, 2023509.34M-28.50M-5.30%
Dec 31, 2022537.84M2.81M0.53%
Dec 31, 2021535.03M40.67M8.23%
Dec 31, 2020494.37M143.05M40.72%
Dec 31, 2019351.32M103.25M41.62%
Dec 31, 2018248.07M71.04M40.13%
Dec 31, 2017177.03M94.14M113.57%
Dec 31, 201682.89M49.80M150.52%
Dec 31, 201533.09M17.60M113.60%
Dec 31, 201415.49M5.13M49.53%
Dec 31, 201310.36M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Enovis2.30B
CONMED1.37B
Tandem Diabetes Care1.04B
Inspire Medical Systems898.74M
Neogen870.40M
Alphatec Holdings815.05M
UFP Technologies631.64M
Axogen251.17M
Revenue Rankings